MHRA – Page 210 – Pharma.Tips

Emulsion Inversion after excipient change: mixing and sampling controls for QA review

Understanding and Addressing Emulsion Inversion Following Excipient Modifications In the pharmaceutical manufacturing arena, an unexpected occurrence like emulsion inversion can pose significant challenges, particularly after changes in excipients. Such incidents…

Assay Oos after temperature excursion: how QA should write CAPA for inspectors

Addressing Assay OOS Following Temperature Excursion: A Comprehensive CAPA Approach for QA Teams In pharmaceutical manufacturing, deviations such as Out of Specification (OOS) results can arise from various factors, including…

Density Mismatch in syrup production: packaging and transport risk assessment

Evaluating Density Mismatch in Syrup Production: A Comprehensive Investigation Approach In pharmaceutical manufacturing, challenges such as density mismatch during syrup production can lead to significant quality concerns, impacting both product…

Sedimentation Rate Oos during filling line setup: mixing, sampling, and hold-time controls

Sedimentation Rate OOS Investigation During Filling Line Setups In the realm of pharmaceutical manufacturing, deviations such as Out-of-Specification (OOS) results for sedimentation rates during filling line setups can lead to…

Fill Volume Variability in syrup production: packaging and transport risk assessment

Assessing Filling Volume Variability in Syrup Production: Investigation and Risk Mitigation Fill volume variability in syrup production can significantly affect product quality and compliance. Variability leading to out-of specification (OOS)…

Assay Oos at accelerated stability: packaging and transport risk assessment

Investigating Assay OOS at Accelerated Stability: Packaging and Transport Risk Assessment In pharmaceutical manufacturing, Out of Specification (OOS) results can pose significant challenges, particularly concerning stability testing. One area of…

Homogeneity Failure after supplier change: mixing, sampling, and hold-time controls

Addressing Homogeneity Issues Post Supplier Change: A Comprehensive Investigation Approach In pharmaceutical manufacturing, maintaining product homogeneity is critical, especially following a supplier change. A failure in homogeneity can lead to…

Microbial Limits Failure in syrup production: mixing, sampling, and hold-time controls

Addressing Microbial Limits Failures in Syrup Production: A Comprehensive Investigation Approach Microbial limits failures can present significant challenges in the production of liquid oral dosage forms such as syrups. Such…

Foaming And Air Entrapment during bulk hold: packaging and transport risk assessment

Investigating Foaming and Air Entrapment during Bulk Hold: A Risk Assessment for Packaging and Transport In pharmaceutical manufacturing, the integrity and quality of liquid oral dosage forms are paramount. One…

Color Change On Stability during EU/UK market supply: investigation flowchart aligned to GMP

Investigation Flowchart for Color Change on Stability during EU/UK Market Supply Color change in liquid oral dosage forms such as syrups and suspensions during stability studies can indicate underlying issues…

Fill Volume Variability after supplier change: mixing, sampling, and hold-time controls

Addressing Fill Volume Variability Following a Supplier Change: Effective Strategies for Control and Compliance In the realm of pharmaceutical manufacturing, particularly when dealing with liquid oral dosage forms, maintaining consistent…

Viscosity Drift during filling line setup: how QA should write CAPA for inspectors

Addressing Viscosity Drift in Filling Line Setup: A Comprehensive Approach for Quality Assurance Viscosity drift during the filling line setup can significantly impact the quality and safety of liquid oral…